| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/ANNRHEUMDIS-2012-201383 |
| P698 | PubMed publication ID | 22586166 |
| P2093 | author name string | Gulen Hatemi | |
| Emire Seyahi | |||
| Sebahattin Yurdakul | |||
| Serdal Ugurlu | |||
| Didar Ucar | |||
| P433 | issue | 9 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 1589-1591 | |
| P577 | publication date | 2012-05-14 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Canakinumab in a patient with juvenile Behcet's syndrome with refractory eye disease | |
| P478 | volume | 71 |
| Q26777598 | A Clinical Picture of the Visual Outcome in Adamantiades-Behçet's Disease |
| Q37632096 | A review and update on orphan drugs for the treatment of noninfectious uveitis |
| Q33910781 | An update on the use of biologic therapies in the management of uveitis in Behçet's disease: a comprehensive review |
| Q58326155 | Anakinra treatment in drug-resistant Behcet’s disease: a case series |
| Q40045785 | Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review |
| Q33908217 | Biological treatments in Behçet's disease: beyond anti-TNF therapy. |
| Q49950020 | Canakinumab treatment in children with familial Mediterranean fever: report from a single center. |
| Q38111308 | Current and future treatments for Behçet's uveitis: road to remission |
| Q40756639 | Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective study |
| Q28082757 | Evasion of inflammasome activation by microbial pathogens |
| Q39096171 | Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study |
| Q35133812 | Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives |
| Q34377832 | Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum. |
| Q42730515 | Knitting the Threads of Silk through Time: Behçet's Disease-Past, Present, and Future |
| Q58728893 | Modulation of three key innate immune pathways for the most common retinal degenerative diseases |
| Q38211813 | Ocular Involvement of Behçet's Syndrome: a Comprehensive Review |
| Q90303781 | Pediatric Behçet's disease - clinical aspects and current concepts |
| Q34274075 | Pharmacotherapy for uveitis: current management and emerging therapy |
| Q27025862 | The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis |
| Q52768652 | The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases. |
| Q37636664 | Treating inflammation by blocking interleukin-1 in humans |
| Q37712230 | Update on the therapy of Behçet disease |
| Q37600483 | Update on the use of systemic biologic agents in the treatment of noninfectious uveitis |
| Q48630386 | [Update: Behçet's disease]. |
Search more.